Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sunley House Capital Management was an investment management business formed in 2014 as a subsidiary of Advent International. It focused on public and select private investment opportunities rather than developing therapeutics, medical devices, or healthcare services. In April 2023, Advent International announced that Sunley House had changed its name to Advent Global Opportunities, indicating that the Sunley House name is no longer the active operating brand. The entity is therefore best characterized as a financial investor platform affiliated with Advent, not a life sciences operating company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sunley House Capital Management.